Citigroup set a $171.00 target price on Clorox (NYSE:CLX) in a report released on Tuesday, February 5th. The brokerage currently has a hold rating on the stock.
CLX has been the subject of a number of other reports. Zacks Investment Research reaffirmed a sell rating on shares of Clorox in a research note on Monday, November 12th. Wells Fargo & Co upped their target price on Clorox from $145.00 to $160.00 and gave the company a market perform rating in a research report on Wednesday, December 12th. They noted that the move was a valuation call. Bank of America restated a neutral rating and set a $170.00 target price (up from $150.00) on shares of Clorox in a research note on Thursday, December 6th. BMO Capital Markets set a $175.00 price target on Clorox and gave the company a buy rating in a research note on Tuesday, February 5th. Finally, Deutsche Bank cut Clorox from a hold rating to a sell rating and set a $123.00 price target for the company. in a research note on Wednesday, October 10th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average price target of $149.08.
CLX stock traded down $0.23 during midday trading on Tuesday, reaching $157.80. 653,260 shares of the company were exchanged, compared to its average volume of 1,150,466. Clorox has a 1-year low of $113.57 and a 1-year high of $167.70. The stock has a market cap of $20.45 billion, a P/E ratio of 25.21, a PEG ratio of 3.96 and a beta of 0.29. The company has a current ratio of 1.15, a quick ratio of 0.66 and a debt-to-equity ratio of 3.08.
Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.32 by $0.08. The firm had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.47 billion. Clorox had a return on equity of 105.97% and a net margin of 12.65%. Clorox’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.77 EPS. On average, equities research analysts predict that Clorox will post 6.33 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $3.84 dividend on an annualized basis and a yield of 2.43%. Clorox’s payout ratio is currently 61.34%.
In other news, CEO Benno O. Dorer sold 152,449 shares of the firm’s stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $164.83, for a total value of $25,128,168.67. Following the completion of the sale, the chief executive officer now directly owns 111,735 shares in the company, valued at approximately $18,417,280.05. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Denise Garner sold 18,366 shares of the firm’s stock in a transaction dated Friday, December 7th. The shares were sold at an average price of $163.53, for a total value of $3,003,391.98. Following the completion of the sale, the senior vice president now owns 16,241 shares of the company’s stock, valued at $2,655,890.73. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 236,361 shares of company stock valued at $38,700,029. Company insiders own 1.40% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its stake in Clorox by 7.7% during the 4th quarter. BlackRock Inc. now owns 10,555,837 shares of the company’s stock valued at $1,627,074,000 after purchasing an additional 752,085 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in shares of Clorox by 48,033.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock worth $44,000 after buying an additional 6,794,834 shares in the last quarter. Morgan Stanley lifted its position in shares of Clorox by 178.2% during the 3rd quarter. Morgan Stanley now owns 3,063,813 shares of the company’s stock worth $460,828,000 after buying an additional 1,962,433 shares in the last quarter. Northern Trust Corp lifted its position in shares of Clorox by 2.8% during the 4th quarter. Northern Trust Corp now owns 2,278,268 shares of the company’s stock worth $351,173,000 after buying an additional 61,663 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Clorox by 21.5% during the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock worth $292,347,000 after buying an additional 335,835 shares in the last quarter. Institutional investors and hedge funds own 77.90% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Technical Analysis
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.